These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9420409)

  • 41. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rare Rh phenotype in a north Indian family.
    Jolly JG; Joshi SR; Choudhary N; Chaudhary RK; Gupta D
    Indian J Pathol Microbiol; 1994 Dec; 37 Suppl():S11-2. PubMed ID: 8613152
    [No Abstract]   [Full Text] [Related]  

  • 43. Rh antibodies after kidney transplantation.
    Gluckman JC; Foucault C; Beaufils H; Luciani J; Cartron J; Frantz PF
    Transplantation; 1981 Sep; 32(3):260-2. PubMed ID: 6792751
    [No Abstract]   [Full Text] [Related]  

  • 44. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
    Collège National des Gynécologues et Obstétriciens Français
    Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Rh-null disease (---/---). Report of the 1st case registered in Spain].
    Gómez Casal F; Tres Sánchez A; Romero Colás MS; Soler Mantilla H; Fuertes Palacio MA; Abós Olivares MD; Bescós Pisón JL; Gutiérrez Martín M
    Med Clin (Barc); 1982 Jul 1-31; 79(3):152-3. PubMed ID: 6810036
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy.
    Novak DJ; Tyler LN; Reddy RL; Barsoom MJ
    J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Molecular genetics and clinical application of Rh blood group system].
    Zhang J; Hou Y; Tang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):246-9. PubMed ID: 12048689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Disastrous consequences of an anti-Rh isoimmunization caused by several intramuscular injections of maternal blood].
    KAPLAN M; MINKOWSKI A; BUHOT S; HUE A
    Nourrisson; 1950; 38(2):73-8. PubMed ID: 15439742
    [No Abstract]   [Full Text] [Related]  

  • 52. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis.
    de Silva PM; Knight RC
    Transfus Med; 1997 Dec; 7(4):323-4. PubMed ID: 9510934
    [No Abstract]   [Full Text] [Related]  

  • 53. Determining the accuracy of a rapid point-of-care test for determining Rh(D) phenotype.
    Herold TJ; Whittaker DS; Glynn T
    Acad Emerg Med; 2005 May; 12(5):474-6. PubMed ID: 15860702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Importance of molecular RhD genotyping in transfusion medicine].
    Drazić V
    Lijec Vjesn; 2007 May; 129 Suppl 3():58-9. PubMed ID: 18972637
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rh sensitization in a general hospital].
    IBAR RS; ROMERO ALVAREZ AM; CARONNI AV; OTTONE JE; LOCKHART M
    Prensa Med Argent; 1950 Sep; 37(37):2202-4. PubMed ID: 14781021
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 58. [Rhesus factor determination of the genome of stereomicroscopy selected amniocytes].
    Ludwig M; Baumann P; Günes A; Gembruch U; Diedrich K
    Zentralbl Gynakol; 1998; 120(9):454-7. PubMed ID: 9796091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 60. Fetal RhD genotyping by maternal serum analysis: a two-year experience.
    Gautier E; Benachi A; Giovangrandi Y; Ernault P; Olivi M; Gaillon T; Costa JM
    Am J Obstet Gynecol; 2005 Mar; 192(3):666-9. PubMed ID: 15746656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.